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Historically, Inonotus Obliquus (Siberian Chaga Mushroom) has been used to
improve the immune system and fight against viral diseases and cancer. Lots
of studies had been performed on I. Obliquus, and have tested the
hypothesis I. Obliquus exhibit general immune-potentiating,
antiinflammatory, antitumor properties, and anti-allergic activities.
This study was designed to determine the efficacy of Inonutus Obliquus on
influenza A mouse infection model. The study was done using a standard
influenza mouse model for human infections previously approved by the
National Institutes of Health. Mice were infected with influenza A H1N1NWS/33 virus, that is often used in NIH approved studies, and were then
treated orally with I. Obliquus extract twice a day for 5-12 days. Markers of
the successful treatment of the virus infection were collected. The
hypothesis that Siberian Chaga Mushroom has efficacy in reducing the
influenza virus caused lung inflammation in mice was tested.

Results and discussion
The animals, that were infected, but were not treated with the Chaga
extract (Group 9), were expected to show higher lung score, body weigh
and higher virus titers than animals, that were not infected, or the
animals that were both infected and later were treated with the extract.
However, Table 1 illustrates how animals, that were infected and were
treated with the extract, had the same high lung score, weight and virus
titer as the ones that were infected and were not treated with the
extract. This data do not support our hypothesis that Siberian Chaga
Mushroom has efficacy in reducing the influenza virus caused lung
inflammation in mice.
Figure1. Average mouse weight per group

Methods
37 BALB/c mice were caged in different groups: 1,3,5,7,9,2,4,6. The Siberian
Chaga extract is made using “energized water” and is harvested in Siberia.
Groups 1,2 and 3,4 were given 1:1 and 1:50 dilutions of the extract and
sterilized water twice a day for 5 days respectively. On day 6 all the animals
from group 1,3,5,7,9 got infected with 90 µl of Influenza A H1N1-NWS/33
virus 1:75 dilution. Groups 1,5 and 2 were given the 1:1 dose of the extract;
groups 3,7 and 4 were given 1:50 dilution of the extract; group 9 and 6 were
given sterile water for injection for 5 days following the infection. On day 12
lungs were harvested from the mice to determine the lung scores, weights
and virus titers. Mice were weighed and mortality noted for fourteen days.
Table1. Table 1 illustrates the average lung score, group weight and virus titer. The data was
collected after the necropsy performed on day 12.

Group number
2
4
6
1
3
5
7
9

Average group lung score
0
0
0
2
2.8
3
2
2

Average group lung
weight
0.15
0.175
0.12
0.326
0.338
0.33
0.34
0.305

Figure 1 illustrates, how animals treated with the different dilutions of
the extract (Group 1,3,5,7) had the same weight loss as the mice that
were infected, but did not get the extract (Group 9). Groups that were
not infected (Group 2,4,6) did not experience a significant weight loss.
Average group virus titer
CCID50/100 uL
<0.67
<0.67
<0.67
4.734
5.034
5.0825
5.4175
4.835
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Conclusions
Siberian Chaga mushroom extract has no
effect on reducing weight loss caused by
influenza virus infection on mice. Taking the
extract prophylactically before getting the
influenza infection or taking it after getting
the infection did not have any significant
effect on helping mice to fight the disease
or reduce their lung inflammation . No
significant change in the weights loss, lung
scores, viral titers and mortality of the mice
within different groups were recorded.
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